Orgenesis Inc. is a fully integrated biopharmaceutical company focused on developing a trans differentiation technology for diabetes and vertically integrating manufacturing that can optimize its abilities to scale up technologies for clinical trials and eventual commercialization, but also to apply disciplined execution to emerging technologies of other cell therapy markets in such areas as cell based cancer immunotherapies and neurodegenerative diseases. This integrated approach supports the Company s business philosophy of bringing to market significant life improving medical treatments.
Quote | Orgenesis Inc. (NASDAQ:ORGS)
Last: | $0.501 |
---|---|
Change Percent: | -0.2% |
Open: | $0.51 |
Close: | $0.502 |
High: | $0.5209 |
Low: | $0.5 |
Volume: | 3,622 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
News | Orgenesis Inc. (NASDAQ:ORGS)
M ajor transformation underway commencing with recent acquisition reasserting full ownership and control over Octomera Secured a $2. 3 million investment from a group incl...
ORMOND BEACH, Fla. and GERMANTOWN, Md., April 10, 2024 (GLOBE NEWSWIRE) -- Germfree, a leading innovator in modular cleanroom infrastructure and services, and Orgenesis Inc. (Nasdaq: ORGS), a global leader in decentralizing cell and gene therapies (CGTs), today announced an asset purchase and str...
Message Board Posts | Orgenesis Inc. (NASDAQ:ORGS)
Subject | By | Source | When |
---|---|---|---|
$ORGS Nice update as Orgenesis CEO Vered Caplan | jedijazz | investorshub | 04/28/2023 2:24:50 PM |
$ORGS - The keynote series will cover how | BlazingStocks | investorshub | 04/25/2023 6:09:36 PM |
Very interested in seeing how the company Orgenesis | BlazingStocks | investorshub | 04/25/2023 6:08:06 PM |
NEWS: Orgenesis CEO Vered Caplan Featured in Keynote | jedijazz | investorshub | 04/25/2023 12:33:32 PM |
Check out the latest analysis for Orgenesis https://simplywall.st/stocks/us/pha | BlazingStocks | investorshub | 04/20/2023 4:12:05 PM |
News, Short Squeeze, Breakout and More Instantly...
Orgenesis Inc. Company Name:
ORGS Stock Symbol:
NASDAQ Market:
M ajor transformation underway commencing with recent acquisition reasserting full ownership and control over Octomera Secured a $2. 3 million investment from a group incl...
ORMOND BEACH, Fla. and GERMANTOWN, Md., April 10, 2024 (GLOBE NEWSWIRE) -- Germfree, a leading innovator in modular cleanroom infrastructure and services, and Orgenesis Inc. (Nasdaq: ORGS), a global leader in decentralizing cell and gene therapies (CGTs), today announced an asset purchase and str...
Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss. Stryve Foods post...